IBD

Question 1

Aminosalicytes

Answer 1

Question 2

what are the drugs that are turning into Mesalamine to be active?

Answer 2

Question 3

various products release differently in the multiple GI tract areas depending on the formulation, allowing for targeted drug therapy

Answer 3

Question 4

Budesonide

Answer 4

Question 5

Predisone

Answer 5

Question 6

Immunomodulators - Thiopurines

Answer 6

Question 7

Immunomodulators:
Methotrexate (Rheumatrex)

Answer 7

Question 8

Anti-TNF monoclonal antibodies

Answer 8

Question 9

Anti-TNF monoclonal antibodies (repeated doses)

Answer 9

Question 10

Anti-IL-12/IL-23:
Ustekinumab

Answer 10

Question 11

Anti-Integrins:
Vedolizumab

Answer 11

Question 12

induction of remission in mild UC: mild proctits, mild left sided colitis, mild extensive colitis

Answer 12

Question 13

Cyclosporine

Answer 13

Question 14

lifestyle modifications evidecne in GERD

Answer 14

Question 15

JAK inhibitors

Answer 15

Question 16

vaccination

Answer 16

Question 17

GERD (infrequent heartburn) and (troublesome sx &/or GERD complications) tx

Answer 17

Question 18

Antiacids

Answer 18

Question 19

Histamine-2 receptor antagonists use and MOA

Answer 19

Question 20

Histamine-2 receptor antagonists AE and DI

Answer 20

Question 21

PPI

Answer 21

Question 22

Omeprazole and Dexlansoprazole

Answer 22

Question 23

PPI short term vs log term use

Answer 23

Question 24

Duration of PPI therapy

Answer 24

Question 25

what is the controversy with PPI?

Answer 25

Question 26

drug therapy for PUD

Answer 26

Question 27

optimized bismuth BQT

Answer 27

Question 28

plyera

Answer 28

Question 29

Rifabutin triple therapy

Answer 29

Question 30

Rifabutin triple therapy AE, CI, DI

Answer 30

Question 31

Vonoprazan

Answer 31

Question 32

PCAB treatment of H.pylori

Answer 32

Question 33

Post Eradication of H. Pylori: - duodenal - small gastric ulcers - large gastric ulcers or complicated

Answer 33

Question 33

1st line regimens for treatment naive patinets with H. pylori infection (PNC allergy vs no PCN allergy)

Answer 33

Question 33

what should be avoided unless there is demonstrated sensativity to Macrolides & Quinolones

Answer 33

Question 34

NSAID-induced ulcers: -inhibition of COX 1 - nonselective NSAIDs carry

Answer 34

Question 35

MOA of NSAIDs

Answer 35

Question 36

what are the risk factors for NSAID PUD: low medium high

Answer 36

Question 37

what are the recommendations for prevention of NSAID- iduced ulcers?

Answer 37

Question 38

risk reduction from NSAIDs: - patients with 1-2 GI risk factors - mutiple GI risks factors - all pts who take NSAIDs plus low-dose aspirin or clopidogrel (or both) should also take a PPI daily

Answer 38

Question 39

Treatment of NSAID-induced ulcers: - PPI if <1cm - PPI if >1cm

Answer 39

Question 40

prevention of recurrent ulcers

Answer 40

Question 41

sucralfate (carafate)

Answer 41

Question 42

Misoprostol (Cytotec)

Answer 42

Question 43

treatment of ulcers NOT attributeable to H pylori or NSAIDs

Answer 43

Question 44

monitoring patinet response

Answer 44